참고문헌
- Melton, L.J. 3rd. Who has osteoporosis? A conflict between clinical and public health perspectives. J. Bone Miner. Res. 15: 2309-2314, 2000. https://doi.org/10.1359/jbmr.2000.15.12.2309
- Halasy-Nagy, J.M., Rodan, G.A., Reszka, A. Inhibition of bone resorption by alendronate and risedronate does not require osteoclast apoptosis. Bone 29: 553-559, 2001. https://doi.org/10.1016/S8756-3282(01)00615-9
- Kwak, H.B., Kim, J.Y., Kim, K.J., Choi, M.K., Kim, J.J. Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. Biol. Pharm. Bull. 32: 1193-1198, 2009. https://doi.org/10.1248/bpb.32.1193
- Khosla, S., Burr, D., Cauley, J., Dempster, D.W., Ebeling, P.R. Felsenberg, D., Gagel, R.F., Gilsanz, V., Guise, T., Koka, S., McCauley, L.K., McGowan, J., McKee, M.D., Mohla, S., Pendrys, D.G., Raisz, L.G., Ruggiero, S.L., Shafer, D.M., Shum, L., Silverman, S.L., Van Poznak, C.H., Watts, N., Woo, S.B., Shane, E. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J. Bone Miner. Res. 22: 1479-1491, 2007. https://doi.org/10.1359/jbmr.0707onj
- Oh, S., Kyung, T.W., Choi, H.S. Curcumin inhibits osteoclastogenesis by decreasing receptor activator of nuclear factor-kappaB ligand (RANKL) in bone marrow stromal cells. Mol. Cells 26: 486-489, 2008.
- Park, C.K., Kim, H.J., Kwak, H.B., Lee, T.H., Bang, M.H., Kim, C.M., Lee, Y., Chung, D.K., Baek, N.I., Kim, J., Lee, Z.H., Kim, H.H. Inhibitory effects of Stewartia koreana on osteoclast differentiation and bone resorption. Int. Immunopharmacol. 7: 1507-1516, 2007. https://doi.org/10.1016/j.intimp.2007.07.016
- Kwak, H.B., Yang, D., Ha, H., Lee, J.H., Kim, H.N., Woo, E.R., Lee, S., Kim, H.H., Lee, Z.H. Tanshinone IIA inhibits osteoclast differentiation through down-regulation of c-Fos and NFATc1. Exp. Mol. Med. 38: 256-264, 2006. https://doi.org/10.1038/emm.2006.31
- Kwak, H.B., Kim, J.H., Kim, D.J., Kwon, Y.M., Oh, J., Kim, Y.K. Effect of water extract of deer antler in osteoclast differentiation. Korean J. Oriental Physiology & pathology, 22: 891-895, 2008.
- Huang, Z.L. Recent developments in pharmacological study and clinical application of Gastrodia elata in China. Zhong. Xi. Yi. Jie. He. Za. Zhi. 5: 251-254, 1985.
- Li, N., Wang, K.J., Chen, J.J., Zhou, J. Phenolic compounds from the rhizomes of Gastrodia elata. J. Asian Nat. Prod. Res. 9: 373-377, 2007. https://doi.org/10.1080/10286020600780979
- Yeung Him-Che. Handbook of Chinese herbs and formulas. Institute of Chinese Medicine, Los Angeles 1985.
- Bown, D. Encyclopaedia of herbs and their uses. Dorling Kindersley, London. 1995.
- Duke, J.A., Ayensu, E.S. Medicinal plants of China. 1985.
- Boyle, W.J., Simonet, W.S., Lacey, D.L. Osteoclast differentiation and activation. Nature, 423: 337-342, 2003. https://doi.org/10.1038/nature01658
- Teitelbaum, S.L., Ross, F.P. Genetic regulation of osteoclast development and function. Nat. Rev. Genet. 4: 638-649, 2003. https://doi.org/10.1038/nrg1122
- Lee, S.E., Woo, K.M., Kim, S.Y., Kim, H.M., Kwack, K., Lee, Z.H., Kim, H.H. The phosphatidylinositol 3-kinase, p38, and extracellular signal-regulated kinase pathways are involved in osteoclast differentiation. Bone 1: 71-77, 2002.
- Tanaka, S., Miyazaki, T., Fukuda, A., Akiyama, T., Kadono, Y., Wakeyama, H., Kono, S., Hoshikawa, S., Nakamura, M., Ohshima, Y., Hikita, A., Nakamura, I., Nakamura, K. Molecular mechanism of the life and death of the osteoclast. Ann. N. Y. Acad. Sci. 1068: 180-186, 2006. https://doi.org/10.1196/annals.1346.020
- Huang, H., Chang, E.J., Ryu, J., Lee, Z.H., Lee, Y., Kim, H.H. Induction of c-Fos and NFATc1 during RANKL-stimulated osteoclast differentiation is mediated by the p38 signaling pathway. Biochem. Biophys. Res. Commun. 351: 99-105, 2006. https://doi.org/10.1016/j.bbrc.2006.10.011
- Chang, E.J., Ha, J., Huang, H., Kim, H.J., Woo, J.H., Lee, Y., Lee, Z.H., Kim, J.H., Kim, H.H. The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation. J. Cell Sci. 121: 2555-2564, 2008. https://doi.org/10.1242/jcs.028217
- Kim, K., Lee, S.H., Kim J.H., Choi, Y., Kim, N. NFATc1 induces osteoclast fusion via up-regulation of Atp6v0d2 and the dendritic cell-specific transmembrane protein (DC-STAMP). Mol. Endocrinol. 22: 176-185, 2008. https://doi.org/10.1210/me.2007-0237
- Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., et al: Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Developmental Cell, 3: 889-901, 2002. https://doi.org/10.1016/S1534-5807(02)00369-6
- Lee, J., Kim, K., Kim, J.H., Jin, H.M., Choi, H.K., Lee, S.H., Kook, H., Kim, K.K., Yokota, Y., Lee, S.Y., Choi, Y., Kim, N. Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation. Blood 107: 2686-2693, 2006. https://doi.org/10.1182/blood-2005-07-2798
- Kim, K., Kim, J., Lee, J., Kim, K., Lee, S., Kim, N. MafB negatively regulates RANKL-mediated osteoclast differentiation. Blood 109: 3253-3259, 2007. https://doi.org/10.1182/blood-2006-09-048249
- Merkel, K.D., Erdmann, J.M., McHugh, K.P., Abu-Amer, Y., Ross, F.P., Teitelbaum, S.L. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am. J. Pathol. 154: 203-210, 1999. https://doi.org/10.1016/S0002-9440(10)65266-2
- Liu, X.D., Zhu, Y.K., Umino, T., Spurzem, J.R., Romberger, D.J., Wang, H., Reed, E., Rennard, S.I. Cigarette smoke inhibits osteogenic differentiation and proliferation of human osteoprogenitor cells in monolayer and three-dimensional collagen gel culture. J. Lab. Clin. Med. 137: 208-219, 2001. https://doi.org/10.1067/mlc.2001.113066
- Redlich, K., Hayer, S., Ricci, R., David, J.P., Tohidast-Akrad, M., Kollias, G., Steiner, G. Smolen, J.S. Wagner, E.F., Schett, G. Osteoclasts are essential for TNF-alpha-mediated joint destruction. J. Clin. Invest. 110: 1419-1427, 2002. https://doi.org/10.1172/JCI0215582
- Lee, J.H., Jin, H., Shim, H.E., Kim, H.N., Ha, H., Lee, Z.H. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Mol. Pharmacol. 77: 17-25, 2010. https://doi.org/10.1124/mol.109.057877
- Dougall, W.C., Glaccum, M., Charrier, K., Rohrbach, K., Brasel, K., De Smedt, T., Daro, E., Smith, J., Tometsko, M.E., Maliszewski, C.R., Armstrong, A., Shen, V., Bain, S., Cosman, D., Anderson, D., Morrissey, P.J., Peschon, J.J., Schuh, J. RANK is essential for osteoclast and lymph node development. Genes Dev. 13: 2412-2424, 1999. https://doi.org/10.1101/gad.13.18.2412
- Takayanagi, H. Osteoimmunology: shared mechanisms and crosstalk between the immune and bone systems. Nat. Rev. Immunol. 7: 292-304, 2007. https://doi.org/10.1038/nri2062
- Asagiri, M., Sato, K., Usami, T., Ochi, S., Nishina, H., Yoshida, H., Morita, I., Wagner, E.F., Mak, T.W., Serfling, E., Takayanagi, H. Autoamplification of NFATc1 expression determines its essential role in bone homeostasis. J. Exp. Med. 202: 1261-1269, 2005. https://doi.org/10.1084/jem.20051150
- Matsuo, K., Galson, D.L., Zhao, C., Peng, L., Laplace, C., Wang, K.Z., Bachler, M.A., Amano, H., Aburatani, H., Ishikawa, H., Wagner, E.F. Nuclear factor of activated T-cells (NFAT) rescues osteoclastogenesis in precursors lacking c-fos. J. Biol. Chem. 279: 26475-26480, 2004. https://doi.org/10.1074/jbc.M313973200
-
Galibert, L., Tometsko, M.E., Anderson, D.M., Cosman, D., Dougall, W.C. The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-
$\kappa B$ , a member of the TNFR superfamily. J. Biol. Chem. 273: 34120-34127, 1998. https://doi.org/10.1074/jbc.273.51.34120 - Sieweke, M., Tekotte, H., Frampton, J., Graf, T. MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation. Cell 85: 49-60, 1996. https://doi.org/10.1016/S0092-8674(00)81081-8